Melanoma Research

Papers
(The H4-Index of Melanoma Research is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Real-world evidence on efficacy and toxicity of targeted therapy in older melanoma patients treated in a tertiary-hospital setting29
Clinicopathological demographics of malignant melanomas of the vulva and vagina in Japan26
Rare immune-related adverse events in a patient with metastatic melanoma: a case report highlighting sarcoidosis-like reactions triggered by immune-checkpoint inhibitors20
Rurality as a predictor of melanoma stage and treatment in Indiana: a retrospective cohort study20
Clinical features, molecular characteristics and surgical management of primary penile mucosal melanoma based on the European Association of Urology Penile Cancer Guidelines18
Analysis of circulating tumor DNA during checkpoint inhibition in metastatic melanoma using a tumor-agnostic panel18
Lack of association between anatomical sites of scalp melanomas and brain metastases does not support direct vascular spread15
Dacarbazine in the management of metastatic melanoma in the era of immune checkpoint therapy: a valid option or obsolete?15
Immune-related adverse events are associated with therapeutic efficacy of immunotherapy in patients with melanoma brain metastases14
Genetic concordance in melanoma: insights from primary tumors and their matched distant metastases14
Study of clinical characteristics and risk factors for amelanotic/hypomelanotic melanoma in an Australian cohort13
Treatment outcomes in patients with advanced mucosal melanoma in Spain: results from the real-world GEM1801 study13
Comprehensive clinical imaging, histopathological analysis and liquid biopsy-based surveillance of human uveal melanoma in a prolonged rabbit xenograft model13
0.20505309104919